FOIA request on Avastin filed with the FDA

[News]

Leaders in the battle with the U.S. Food and Drug Administration to retain metastatic breast cancer (mbc) as an indication for the drug Avastin today filed a Freedom of Information Act ("FOIA") request with the FDA.

More... (http://www.news-medical.net/news/20110428/FOIA-request-on-Avastin-filed-with-the-FDA.aspx)